|By PR Newswire||
|March 18, 2014 05:24 PM EDT||
NEW YORK, March 18, 2014 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Geron Corporation ("Geron" or the "Company") (NasdaqGS: GERN) (CUSIP: 374163103). Investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 237.
The investigation concerns whether Geron and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
On March 12, 2014, the Company announced that it has received verbal notice from the U.S. Food and Drug Administration ("FDA") that its investigational new drug application for its experimental drug, imetelstat for blood disorders, has been placed on full clinical hold, affecting its mid-stage trials of imetelstat because of low-grade liver function test abnormalities.
On this news, shares of Geron fell $2.71 to $1.69, or more than 61.59%, on unusually heavy trading volume, on March 12, 2014.
The Pomerantz Firm, with offices in New York, Chicago, San Diego, and Florida, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.
Robert S. Willoughby
SOURCE Pomerantz LLP
Aug. 30, 2016 12:00 AM EDT Reads: 1,662
Aug. 29, 2016 10:15 PM EDT Reads: 287
Aug. 29, 2016 10:00 PM EDT Reads: 2,485
Aug. 29, 2016 08:30 PM EDT Reads: 2,440
Aug. 29, 2016 08:15 PM EDT Reads: 1,869
Aug. 29, 2016 08:00 PM EDT Reads: 913
Aug. 29, 2016 07:00 PM EDT Reads: 1,980
Aug. 29, 2016 06:45 PM EDT Reads: 839
Aug. 29, 2016 06:15 PM EDT Reads: 796
Aug. 29, 2016 06:15 PM EDT Reads: 331
Aug. 29, 2016 04:30 PM EDT Reads: 3,567
Aug. 29, 2016 02:15 PM EDT Reads: 3,745
Aug. 29, 2016 02:00 PM EDT Reads: 1,007
Data is the fuel that drives the machine learning algorithmic engines and ultimately provides the business value. In his session at Cloud Expo, Ed Featherston, a director and senior enterprise architect at Collaborative Consulting, will discuss the key considerations around quality, volume, timeliness, and pedigree that must be dealt with in order to properly fuel that engine.
Aug. 29, 2016 12:45 PM EDT Reads: 2,029
There is growing need for data-driven applications and the need for digital platforms to build these apps. In his session at 19th Cloud Expo, Muddu Sudhakar, VP and GM of Security & IoT at Splunk, will cover different PaaS solutions and Big Data platforms that are available to build applications. In addition, AI and machine learning are creating new requirements that developers need in the building of next-gen apps. The next-generation digital platforms have some of the past platform needs a...
Aug. 29, 2016 12:15 PM EDT Reads: 845